Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared with infliximab in children.
Daniela Kroshinsky, MD, MPH
Advertisement
Daniela Kroshinsky, MD, MPH, works in the Department of Dermatology at the Duke University School of Medicine.
Articles by Daniela Kroshinsky, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Physical Activity, Vaccination May Protect Against Long COVID
2
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
3
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
4
Real-World Data Highlight Value of NOTCH1 Screening in CLL
5
